Global Benign Prostatic Hyperplasia Devices Market Insights, Forecast to 2029
Table of Contents1 Study Coverage
1.1 Benign Prostatic Hyperplasia Devices Product Introduction
1.2 Market by Type
1.2.1 Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Transurethral Resection of the Prostate (TURP)
1.2.3 Transurethral Microwave Therapy (TUMT)
1.2.4 Transurethral Needle Ablation of the Prostate (TUNA)
1.2.5 Laser Surgery
1.2.6 Prostatic Stenting
1.2.7 Others
1.3 Market by Application
1.3.1 Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals and Clinics
1.3.3 Ambulatory Surgical Centers(ASC)
1.3.4 Home
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Benign Prostatic Hyperplasia Devices Sales Estimates and Forecasts 2018-2029
2.2 Global Benign Prostatic Hyperplasia Devices Revenue by Region
2.2.1 Global Benign Prostatic Hyperplasia Devices Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Benign Prostatic Hyperplasia Devices Revenue by Region (2018-2023)
2.2.3 Global Benign Prostatic Hyperplasia Devices Revenue by Region (2024-2029)
2.2.4 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Region (2018-2029)
2.3 Global Benign Prostatic Hyperplasia Devices Sales Estimates and Forecasts 2018-2029
2.4 Global Benign Prostatic Hyperplasia Devices Sales by Region
2.4.1 Global Benign Prostatic Hyperplasia Devices Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Benign Prostatic Hyperplasia Devices Sales by Region (2018-2023)
2.4.3 Global Benign Prostatic Hyperplasia Devices Sales by Region (2024-2029)
2.4.4 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Benign Prostatic Hyperplasia Devices Sales by Manufacturers
3.1.1 Global Benign Prostatic Hyperplasia Devices Sales by Manufacturers (2018-2023)
3.1.2 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Benign Prostatic Hyperplasia Devices in 2022
3.2 Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturers
3.2.1 Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturers (2018-2023)
3.2.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Benign Prostatic Hyperplasia Devices Revenue in 2022
3.3 Global Key Players of Benign Prostatic Hyperplasia Devices, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Benign Prostatic Hyperplasia Devices Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Benign Prostatic Hyperplasia Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Product Offered and Application
3.8 Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Benign Prostatic Hyperplasia Devices Sales by Type
4.1.1 Global Benign Prostatic Hyperplasia Devices Historical Sales by Type (2018-2023)
4.1.2 Global Benign Prostatic Hyperplasia Devices Forecasted Sales by Type (2024-2029)
4.1.3 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Type (2018-2029)
4.2 Global Benign Prostatic Hyperplasia Devices Revenue by Type
4.2.1 Global Benign Prostatic Hyperplasia Devices Historical Revenue by Type (2018-2023)
4.2.2 Global Benign Prostatic Hyperplasia Devices Forecasted Revenue by Type (2024-2029)
4.2.3 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Type (2018-2029)
4.3 Global Benign Prostatic Hyperplasia Devices Price by Type
4.3.1 Global Benign Prostatic Hyperplasia Devices Price by Type (2018-2023)
4.3.2 Global Benign Prostatic Hyperplasia Devices Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Benign Prostatic Hyperplasia Devices Sales by Application
5.1.1 Global Benign Prostatic Hyperplasia Devices Historical Sales by Application (2018-2023)
5.1.2 Global Benign Prostatic Hyperplasia Devices Forecasted Sales by Application (2024-2029)
5.1.3 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Application (2018-2029)
5.2 Global Benign Prostatic Hyperplasia Devices Revenue by Application
5.2.1 Global Benign Prostatic Hyperplasia Devices Historical Revenue by Application (2018-2023)
5.2.2 Global Benign Prostatic Hyperplasia Devices Forecasted Revenue by Application (2024-2029)
5.2.3 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Application (2018-2029)
5.3 Global Benign Prostatic Hyperplasia Devices Price by Application
5.3.1 Global Benign Prostatic Hyperplasia Devices Price by Application (2018-2023)
5.3.2 Global Benign Prostatic Hyperplasia Devices Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Benign Prostatic Hyperplasia Devices Market Size by Type
6.1.1 US & Canada Benign Prostatic Hyperplasia Devices Sales by Type (2018-2029)
6.1.2 US & Canada Benign Prostatic Hyperplasia Devices Revenue by Type (2018-2029)
6.2 US & Canada Benign Prostatic Hyperplasia Devices Market Size by Application
6.2.1 US & Canada Benign Prostatic Hyperplasia Devices Sales by Application (2018-2029)
6.2.2 US & Canada Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2029)
6.3 US & Canada Benign Prostatic Hyperplasia Devices Market Size by Country
6.3.1 US & Canada Benign Prostatic Hyperplasia Devices Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Benign Prostatic Hyperplasia Devices Sales by Country (2018-2029)
6.3.3 US & Canada Benign Prostatic Hyperplasia Devices Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Benign Prostatic Hyperplasia Devices Market Size by Type
7.1.1 Europe Benign Prostatic Hyperplasia Devices Sales by Type (2018-2029)
7.1.2 Europe Benign Prostatic Hyperplasia Devices Revenue by Type (2018-2029)
7.2 Europe Benign Prostatic Hyperplasia Devices Market Size by Application
7.2.1 Europe Benign Prostatic Hyperplasia Devices Sales by Application (2018-2029)
7.2.2 Europe Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2029)
7.3 Europe Benign Prostatic Hyperplasia Devices Market Size by Country
7.3.1 Europe Benign Prostatic Hyperplasia Devices Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Benign Prostatic Hyperplasia Devices Sales by Country (2018-2029)
7.3.3 Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Benign Prostatic Hyperplasia Devices Market Size
8.1.1 China Benign Prostatic Hyperplasia Devices Sales (2018-2029)
8.1.2 China Benign Prostatic Hyperplasia Devices Revenue (2018-2029)
8.2 China Benign Prostatic Hyperplasia Devices Market Size by Application
8.2.1 China Benign Prostatic Hyperplasia Devices Sales by Application (2018-2029)
8.2.2 China Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Benign Prostatic Hyperplasia Devices Market Size by Type
9.1.1 Asia Benign Prostatic Hyperplasia Devices Sales by Type (2018-2029)
9.1.2 Asia Benign Prostatic Hyperplasia Devices Revenue by Type (2018-2029)
9.2 Asia Benign Prostatic Hyperplasia Devices Market Size by Application
9.2.1 Asia Benign Prostatic Hyperplasia Devices Sales by Application (2018-2029)
9.2.2 Asia Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2029)
9.3 Asia Benign Prostatic Hyperplasia Devices Sales by Region
9.3.1 Asia Benign Prostatic Hyperplasia Devices Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Benign Prostatic Hyperplasia Devices Revenue by Region (2018-2029)
9.3.3 Asia Benign Prostatic Hyperplasia Devices Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Market Size by Type
10.1.1 Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Market Size by Application
10.2.1 Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Sales by Country
10.3.1 Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Lumenis
11.1.1 Lumenis Company Information
11.1.2 Lumenis Overview
11.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Lumenis Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lumenis Recent Developments
11.2 Olympus corporation
11.2.1 Olympus corporation Company Information
11.2.2 Olympus corporation Overview
11.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Olympus corporation Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Olympus corporation Recent Developments
11.3 Urologix
11.3.1 Urologix Company Information
11.3.2 Urologix Overview
11.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Urologix Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Urologix Recent Developments
11.4 Boston Scientific corporation
11.4.1 Boston Scientific corporation Company Information
11.4.2 Boston Scientific corporation Overview
11.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boston Scientific corporation Recent Developments
11.5 Lisa Laser
11.5.1 Lisa Laser Company Information
11.5.2 Lisa Laser Overview
11.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Lisa Laser Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lisa Laser Recent Developments
11.6 Medifocus
11.6.1 Medifocus Company Information
11.6.2 Medifocus Overview
11.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Medifocus Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Medifocus Recent Developments
11.7 Neotrac
11.7.1 Neotrac Company Information
11.7.2 Neotrac Overview
11.7.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Neotrac Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Neotrac Recent Developments
11.8 ProArc Medical LTD
11.8.1 ProArc Medical LTD Company Information
11.8.2 ProArc Medical LTD Overview
11.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 ProArc Medical LTD Recent Developments
11.9 Urotech GMBH
11.9.1 Urotech GMBH Company Information
11.9.2 Urotech GMBH Overview
11.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Urotech GMBH Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Urotech GMBH Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Benign Prostatic Hyperplasia Devices Industry Chain Analysis
12.2 Benign Prostatic Hyperplasia Devices Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Benign Prostatic Hyperplasia Devices Production Mode & Process
12.4 Benign Prostatic Hyperplasia Devices Sales and Marketing
12.4.1 Benign Prostatic Hyperplasia Devices Sales Channels
12.4.2 Benign Prostatic Hyperplasia Devices Distributors
12.5 Benign Prostatic Hyperplasia Devices Customers
13 Market Dynamics
13.1 Benign Prostatic Hyperplasia Devices Industry Trends
13.2 Benign Prostatic Hyperplasia Devices Market Drivers
13.3 Benign Prostatic Hyperplasia Devices Market Challenges
13.4 Benign Prostatic Hyperplasia Devices Market Restraints
14 Key Findings in The Global Benign Prostatic Hyperplasia Devices Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of TablesTable 1. Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Transurethral Resection of the Prostate (TURP)
Table 3. Major Manufacturers of Transurethral Microwave Therapy (TUMT)
Table 4. Major Manufacturers of Transurethral Needle Ablation of the Prostate (TUNA)
Table 5. Major Manufacturers of Laser Surgery
Table 6. Major Manufacturers of Prostatic Stenting
Table 7. Major Manufacturers of Others
Table 8. Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Benign Prostatic Hyperplasia Devices Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Benign Prostatic Hyperplasia Devices Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Benign Prostatic Hyperplasia Devices Revenue by Region (2024-2029) & (US$ Million)
Table 12. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Region (2018-2023)
Table 13. Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Region (2024-2029)
Table 14. Global Benign Prostatic Hyperplasia Devices Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 15. Global Benign Prostatic Hyperplasia Devices Sales by Region (2018-2023) & (K Units)
Table 16. Global Benign Prostatic Hyperplasia Devices Sales by Region (2024-2029) & (K Units)
Table 17. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Region (2018-2023)
Table 18. Global Benign Prostatic Hyperplasia Devices Sales Market Share by Region (2024-2029)
Table 19. Global Benign Prostatic Hyperplasia Devices Sales by Manufacturers (2018-2023) & (K Units)
Table 20. Global Benign Prostatic Hyperplasia Devices Sales Share by Manufacturers (2018-2023)
Table 21. Global Benign Prostatic Hyperplasia Devices Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Benign Prostatic Hyperplasia Devices Revenue Share by Manufacturers (2018-2023)
Table 23. Global Key Players of Benign Prostatic Hyperplasia Devices, Industry Ranking, 2021 VS 2022 VS 2023
Table 24. Benign Prostatic Hyperplasia Devices Price by Manufacturers 2018-2023 (USD/Unit)
Table 25. Global Benign Prostatic Hyperplasia Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Benign Prostatic Hyperplasia Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Devices as of 2022)
Table 27. Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Product Offered and Application
Table 29. Global Key Manufacturers of Benign Prostatic Hyperplasia Devices, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Benign Prostatic Hyperplasia Devices Sales by Type (2018-2023) & (K Units)
Table 32. Global Benign Prostatic Hyperplasia Devices Sales by Type (2024-2029) & (K Units)
Table 33. Global Benign Prostatic Hyperplasia Devices Sales Share by Type (2018-2023)
Table 34. Global Benign Prostatic Hyperplasia Devices Sales Share by Type (2024-2029)
Table 35. Global Benign Prostatic Hyperplasia Devices Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Benign Prostatic Hyperplasia Devices Revenue by Type (2024-2029) & (US$ Million)
Table 37. Global Benign Prostatic Hyperplasia Devices Revenue Share by Type (2018-2023)
Table 38. Global Benign Prostatic Hyperplasia Devices Revenue Share by Type (2024-2029)
Table 39. Benign Prostatic Hyperplasia Devices Price by Type (2018-2023) & (USD/Unit)
Table 40. Global Benign Prostatic Hyperplasia Devices Price Forecast by Type (2024-2029) & (USD/Unit)
Table 41. Global Benign Prostatic Hyperplasia Devices Sales by Application (2018-2023) & (K Units)
Table 42. Global Benign Prostatic Hyperplasia Devices Sales by Application (2024-2029) & (K Units)
Table 43. Global Benign Prostatic Hyperplasia Devices Sales Share by Application (2018-2023)
Table 44. Global Benign Prostatic Hyperplasia Devices Sales Share by Application (2024-2029)
Table 45. Global Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Benign Prostatic Hyperplasia Devices Revenue by Application (2024-2029) & (US$ Million)
Table 47. Global Benign Prostatic Hyperplasia Devices Revenue Share by Application (2018-2023)
Table 48. Global Benign Prostatic Hyperplasia Devices Revenue Share by Application (2024-2029)
Table 49. Benign Prostatic Hyperplasia Devices Price by Application (2018-2023) & (USD/Unit)
Table 50. Global Benign Prostatic Hyperplasia Devices Price Forecast by Application (2024-2029) & (USD/Unit)
Table 51. US & Canada Benign Prostatic Hyperplasia Devices Sales by Type (2018-2023) & (K Units)
Table 52. US & Canada Benign Prostatic Hyperplasia Devices Sales by Type (2024-2029) & (K Units)
Table 53. US & Canada Benign Prostatic Hyperplasia Devices Revenue by Type (2018-2023) & (US$ Million)
Table 54. US & Canada Benign Prostatic Hyperplasia Devices Revenue by Type (2024-2029) & (US$ Million)
Table 55. US & Canada Benign Prostatic Hyperplasia Devices Sales by Application (2018-2023) & (K Units)
Table 56. US & Canada Benign Prostatic Hyperplasia Devices Sales by Application (2024-2029) & (K Units)
Table 57. US & Canada Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2023) & (US$ Million)
Table 58. US & Canada Benign Prostatic Hyperplasia Devices Revenue by Application (2024-2029) & (US$ Million)
Table 59. US & Canada Benign Prostatic Hyperplasia Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 60. US & Canada Benign Prostatic Hyperplasia Devices Revenue by Country (2018-2023) & (US$ Million)
Table 61. US & Canada Benign Prostatic Hyperplasia Devices Revenue by Country (2024-2029) & (US$ Million)
Table 62. US & Canada Benign Prostatic Hyperplasia Devices Sales by Country (2018-2023) & (K Units)
Table 63. US & Canada Benign Prostatic Hyperplasia Devices Sales by Country (2024-2029) & (K Units)
Table 64. Europe Benign Prostatic Hyperplasia Devices Sales by Type (2018-2023) & (K Units)
Table 65. Europe Benign Prostatic Hyperplasia Devices Sales by Type (2024-2029) & (K Units)
Table 66. Europe Benign Prostatic Hyperplasia Devices Revenue by Type (2018-2023) & (US$ Million)
Table 67. Europe Benign Prostatic Hyperplasia Devices Revenue by Type (2024-2029) & (US$ Million)
Table 68. Europe Benign Prostatic Hyperplasia Devices Sales by Application (2018-2023) & (K Units)
Table 69. Europe Benign Prostatic Hyperplasia Devices Sales by Application (2024-2029) & (K Units)
Table 70. Europe Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2023) & (US$ Million)
Table 71. Europe Benign Prostatic Hyperplasia Devices Revenue by Application (2024-2029) & (US$ Million)
Table 72. Europe Benign Prostatic Hyperplasia Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 73. Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2018-2023) & (US$ Million)
Table 74. Europe Benign Prostatic Hyperplasia Devices Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Benign Prostatic Hyperplasia Devices Sales by Country (2018-2023) & (K Units)
Table 76. Europe Benign Prostatic Hyperplasia Devices Sales by Country (2024-2029) & (K Units)
Table 77. China Benign Prostatic Hyperplasia Devices Sales by Type (2018-2023) & (K Units)
Table 78. China Benign Prostatic Hyperplasia Devices Sales by Type (2024-2029) & (K Units)
Table 79. China Benign Prostatic Hyperplasia Devices Revenue by Type (2018-2023) & (US$ Million)
Table 80. China Benign Prostatic Hyperplasia Devices Revenue by Type (2024-2029) & (US$ Million)
Table 81. China Benign Prostatic Hyperplasia Devices Sales by Application (2018-2023) & (K Units)
Table 82. China Benign Prostatic Hyperplasia Devices Sales by Application (2024-2029) & (K Units)
Table 83. China Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2023) & (US$ Million)
Table 84. China Benign Prostatic Hyperplasia Devices Revenue by Application (2024-2029) & (US$ Million)
Table 85. Asia Benign Prostatic Hyperplasia Devices Sales by Type (2018-2023) & (K Units)
Table 86. Asia Benign Prostatic Hyperplasia Devices Sales by Type (2024-2029) & (K Units)
Table 87. Asia Benign Prostatic Hyperplasia Devices Revenue by Type (2018-2023) & (US$ Million)
Table 88. Asia Benign Prostatic Hyperplasia Devices Revenue by Type (2024-2029) & (US$ Million)
Table 89. Asia Benign Prostatic Hyperplasia Devices Sales by Application (2018-2023) & (K Units)
Table 90. Asia Benign Prostatic Hyperplasia Devices Sales by Application (2024-2029) & (K Units)
Table 91. Asia Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2023) & (US$ Million)
Table 92. Asia Benign Prostatic Hyperplasia Devices Revenue by Application (2024-2029) & (US$ Million)
Table 93. Asia Benign Prostatic Hyperplasia Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 94. Asia Benign Prostatic Hyperplasia Devices Revenue by Region (2018-2023) & (US$ Million)
Table 95. Asia Benign Prostatic Hyperplasia Devices Revenue by Region (2024-2029) & (US$ Million)
Table 96. Asia Benign Prostatic Hyperplasia Devices Sales by Region (2018-2023) & (K Units)
Table 97. Asia Benign Prostatic Hyperplasia Devices Sales by Region (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Sales by Type (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Sales by Type (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue by Type (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue by Type (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Sales by Application (2018-2023) & (K Units)
Table 103. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Sales by Application (2024-2029) & (K Units)
Table 104. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue by Application (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue by Application (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 107. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue by Country (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Revenue by Country (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Sales by Country (2018-2023) & (K Units)
Table 110. Middle East, Africa and Latin America Benign Prostatic Hyperplasia Devices Sales by Country (2024-2029) & (K Units)
Table 111. Lumenis Company Information
Table 112. Lumenis Description and Major Businesses
Table 113. Lumenis Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 114. Lumenis Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Lumenis Recent Developments
Table 116. Olympus corporation Company Information
Table 117. Olympus corporation Description and Major Businesses
Table 118. Olympus corporation Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 119. Olympus corporation Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Olympus corporation Recent Developments
Table 121. Urologix Company Information
Table 122. Urologix Description and Major Businesses
Table 123. Urologix Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 124. Urologix Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Urologix Recent Developments
Table 126. Boston Scientific corporation Company Information
Table 127. Boston Scientific corporation Description and Major Businesses
Table 128. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 129. Boston Scientific corporation Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Boston Scientific corporation Recent Developments
Table 131. Lisa Laser Company Information
Table 132. Lisa Laser Description and Major Businesses
Table 133. Lisa Laser Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 134. Lisa Laser Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Lisa Laser Recent Developments
Table 136. Medifocus Company Information
Table 137. Medifocus Description and Major Businesses
Table 138. Medifocus Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 139. Medifocus Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Medifocus Recent Developments
Table 141. Neotrac Company Information
Table 142. Neotrac Description and Major Businesses
Table 143. Neotrac Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 144. Neotrac Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Neotrac Recent Developments
Table 146. ProArc Medical LTD Company Information
Table 147. ProArc Medical LTD Description and Major Businesses
Table 148. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 149. ProArc Medical LTD Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. ProArc Medical LTD Recent Developments
Table 151. Urotech GMBH Company Information
Table 152. Urotech GMBH Description and Major Businesses
Table 153. Urotech GMBH Benign Prostatic Hyperplasia Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 154. Urotech GMBH Benign Prostatic Hyperplasia Devices Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Urotech GMBH Recent Developments
Table 156. Key Raw Materials Lists
Table 157. Raw Materials Key Suppliers Lists
Table 158. Benign Prostatic Hyperplasia Devices Distributors List
Table 159. Benign Prostatic Hyperplasia Devices Customers List
Table 160. Benign Prostatic Hyperplasia Devices Market Trends
Table 161. Benign Prostatic Hyperplasia Devices Market Drivers
Table 162. Benign Prostatic Hyperplasia Devices Market Challenges
Table 163. Benign Prostatic Hyperplasia Devices Market Restraints
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of FiguresFigure 1. Benign Prostatic Hyperplasia Devices Product Picture
Figure 2. Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Benign Prostatic Hyperplasia Devices Market Share by Type in 2022 & 2029
Figure 4. Transurethral Resection of the Prostate (TURP) Product Picture
Figure 5. Transurethral Microwave Therapy (TUMT) Product Picture
Figure 6. Transurethral Needle Ablation of the Prostate (TUNA) Product Picture
Figure 7. Laser Surgery Product Picture
Figure 8. Prostatic Stenting Product Picture
Figure 9. Others Product Picture
Figure 10. Global Benign Prostatic Hyperplasia Devices Market Size Growth Rate by Application, 2018 VS 2022 VS 2029